Keyphrases
96-well Plate
9%
Antiviral Activity
9%
Biological Evaluation
9%
Biological Function
6%
Broad-spectrum Activity
9%
Broad-spectrum Antivirals
18%
Budding Yeast
9%
Cell Culture Model
6%
Chapel Hill
6%
Chemical Compounds
27%
Chemical Screen
100%
Compounded Drugs
9%
Coronavirus
18%
Coronavirus Model
9%
Diverse Groups
6%
Diversity Set
9%
Group Diversity
9%
Growth Inhibition
9%
High-throughput
12%
High-throughput Screening
6%
Human Body
9%
Human Coronavirus (HCoV)
36%
Human Pathogens
9%
Life-limiting Conditions
9%
Lower Respiratory Tract Infection
18%
Microbial Pathogens
9%
Molecular Clone
9%
Molecular Library
9%
Molecular Probe
9%
Murine Model
9%
Novel Assay
9%
Novel Medications
9%
Nsp1
18%
Production Facilities
9%
Project Narratives
6%
Recombinant
6%
Reporter Gene
9%
Respiratory Disease
9%
Saccharomyces Cerevisiae
6%
Screening Effort
9%
Secondary Screen
9%
Severe Acute Respiratory Syndrome
66%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
6%
Severe Pneumonia
9%
Small Molecule Inhibitors
6%
Structural Information
6%
Test Tube
9%
University of North Carolina
6%
University of Virginia
6%
Upper Respiratory Tract Infection
6%
Viral Gene
6%
Virus
6%
Virus Replication
6%
Yeast Assay
100%
Young children
9%
Immunology and Microbiology
Antiviral Activity
10%
Biological Functions
10%
Budding Yeast
10%
Cell Culture
6%
Coronaviridae
40%
Coronavirinae
30%
High Throughput Screening
6%
Human Pathogen
10%
Infectious Agent
6%
Lower Respiratory Tract
20%
Molecular Library
10%
Molecular Probe
10%
Murine
6%
Reporter Gene
10%
Saccharomyces cerevisiae
6%
SARS Coronavirus
6%
Severe Acute Respiratory Syndrome
100%
Severe Acute Respiratory Syndrome Coronavirus
10%
Upper Respiratory Tract
6%
Viral Replication
6%
Virus Gene
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antiviral Activity
9%
Antivirus Agent
18%
Budding Yeast
9%
Cell Culture
6%
Coronaviridae
36%
Coronavirinae
27%
Disease
12%
Drug
9%
High-Throughput Screening
9%
Infection
6%
Infectious Agent
6%
Lower Respiratory Tract Infection
18%
Murine
6%
Pathogenesis
9%
Recombinant
9%
Respiratory Tract Disease
6%
Saccharomyces cerevisiae
9%
SARS Coronavirus
6%
Severe Acute Respiratory Syndrome
100%
Upper Respiratory Tract Infection
6%